 Nidhya Navanandan
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 14 | 2024 | 2212 | 3.810 |
Why?
| | Anti-Asthmatic Agents | 5 | 2024 | 371 | 1.840 |
Why?
| | Emergency Service, Hospital | 12 | 2024 | 1896 | 1.370 |
Why?
| | Pneumonia | 7 | 2023 | 600 | 1.370 |
Why?
| | Respiratory Tract Infections | 4 | 2024 | 372 | 1.050 |
Why?
| | Respiratory Sounds | 2 | 2024 | 120 | 1.040 |
Why?
| | Community-Acquired Infections | 5 | 2023 | 153 | 0.890 |
Why?
| | Recurrence | 2 | 2024 | 993 | 0.880 |
Why?
| | Child | 26 | 2024 | 20636 | 0.810 |
Why?
| | Virus Diseases | 2 | 2023 | 209 | 0.780 |
Why?
| | Severity of Illness Index | 4 | 2024 | 2703 | 0.740 |
Why?
| | Airway Resistance | 1 | 2020 | 38 | 0.690 |
Why?
| | Oscillometry | 1 | 2020 | 37 | 0.680 |
Why?
| | Adrenal Cortex Hormones | 4 | 2024 | 518 | 0.650 |
Why?
| | Medicaid | 1 | 2024 | 433 | 0.650 |
Why?
| | Staphylococcus aureus | 1 | 2023 | 434 | 0.640 |
Why?
| | Child, Preschool | 13 | 2024 | 10378 | 0.600 |
Why?
| | Glucocorticoids | 2 | 2020 | 572 | 0.580 |
Why?
| | Patient Discharge Summaries | 1 | 2017 | 10 | 0.550 |
Why?
| | Biomedical Research | 1 | 2023 | 632 | 0.550 |
Why?
| | Physicians, Primary Care | 1 | 2020 | 226 | 0.540 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 75 | 0.530 |
Why?
| | Pulmonary Embolism | 1 | 2019 | 202 | 0.530 |
Why?
| | Dexamethasone | 3 | 2024 | 339 | 0.480 |
Why?
| | Emergency Medical Services | 2 | 2021 | 518 | 0.470 |
Why?
| | Health Literacy | 1 | 2017 | 161 | 0.460 |
Why?
| | Prednisone | 3 | 2020 | 230 | 0.450 |
Why?
| | Physicians | 1 | 2022 | 858 | 0.440 |
Why?
| | Prospective Studies | 10 | 2024 | 7035 | 0.400 |
Why?
| | Acute Disease | 4 | 2024 | 961 | 0.380 |
Why?
| | Humans | 28 | 2024 | 128020 | 0.380 |
Why?
| | Patient Readmission | 1 | 2017 | 663 | 0.370 |
Why?
| | Bronchodilator Agents | 3 | 2024 | 243 | 0.370 |
Why?
| | Prednisolone | 2 | 2020 | 82 | 0.340 |
Why?
| | Caregivers | 1 | 2017 | 810 | 0.320 |
Why?
| | Male | 14 | 2024 | 62758 | 0.280 |
Why?
| | Patient Discharge | 3 | 2024 | 850 | 0.260 |
Why?
| | Disease Progression | 2 | 2024 | 2598 | 0.240 |
Why?
| | Hospitalization | 4 | 2022 | 2057 | 0.240 |
Why?
| | Infant | 7 | 2024 | 8912 | 0.240 |
Why?
| | Risk Factors | 4 | 2024 | 9696 | 0.230 |
Why?
| | Rhinovirus | 1 | 2024 | 56 | 0.230 |
Why?
| | Picornaviridae Infections | 1 | 2024 | 45 | 0.220 |
Why?
| | Quality of Life | 4 | 2024 | 2672 | 0.220 |
Why?
| | Enterotoxins | 1 | 2023 | 89 | 0.210 |
Why?
| | Female | 12 | 2024 | 68017 | 0.210 |
Why?
| | Bronchiolitis | 1 | 2024 | 87 | 0.200 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2023 | 68 | 0.200 |
Why?
| | Viruses | 1 | 2023 | 99 | 0.190 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2023 | 119 | 0.190 |
Why?
| | Magnesium | 1 | 2022 | 150 | 0.190 |
Why?
| | Educational Status | 1 | 2024 | 470 | 0.190 |
Why?
| | Administration, Intravenous | 1 | 2022 | 137 | 0.190 |
Why?
| | Delphi Technique | 1 | 2023 | 221 | 0.190 |
Why?
| | Dyspnea | 1 | 2023 | 238 | 0.180 |
Why?
| | Schools | 1 | 2024 | 436 | 0.170 |
Why?
| | Allergens | 1 | 2023 | 381 | 0.170 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5353 | 0.170 |
Why?
| | Consensus | 1 | 2023 | 607 | 0.160 |
Why?
| | Thrombectomy | 1 | 2019 | 59 | 0.150 |
Why?
| | Administration, Oral | 1 | 2020 | 766 | 0.150 |
Why?
| | Adolescent | 5 | 2024 | 20158 | 0.150 |
Why?
| | Vena Cava Filters | 1 | 2019 | 59 | 0.150 |
Why?
| | Self Report | 1 | 2022 | 796 | 0.150 |
Why?
| | Infant, Newborn | 3 | 2024 | 5688 | 0.140 |
Why?
| | Ipratropium | 1 | 2017 | 6 | 0.140 |
Why?
| | Influenza, Human | 1 | 2023 | 600 | 0.140 |
Why?
| | Nebulizers and Vaporizers | 1 | 2017 | 81 | 0.130 |
Why?
| | Albuterol | 1 | 2017 | 103 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2020 | 860 | 0.130 |
Why?
| | Retrospective Studies | 3 | 2024 | 14404 | 0.130 |
Why?
| | Single-Blind Method | 1 | 2017 | 267 | 0.130 |
Why?
| | Sepsis | 1 | 2022 | 562 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 146 | 0.130 |
Why?
| | Phenotype | 1 | 2023 | 3039 | 0.120 |
Why?
| | Prognosis | 1 | 2023 | 3766 | 0.120 |
Why?
| | Health Surveys | 1 | 2017 | 491 | 0.120 |
Why?
| | Anticoagulants | 1 | 2019 | 615 | 0.110 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1199 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2024 | 10110 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2017 | 500 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 624 | 0.100 |
Why?
| | Biomarkers | 1 | 2023 | 3874 | 0.100 |
Why?
| | Primary Health Care | 1 | 2020 | 1639 | 0.080 |
Why?
| | United States | 2 | 2024 | 13785 | 0.080 |
Why?
| | Pediatrics | 1 | 2017 | 1044 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1272 | 0.070 |
Why?
| | Adult | 2 | 2020 | 35177 | 0.060 |
Why?
| | Uncertainty | 1 | 2024 | 114 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 45 | 0.050 |
Why?
| | Treatment Failure | 1 | 2024 | 338 | 0.050 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1689 | 0.050 |
Why?
| | Fever | 1 | 2022 | 295 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 206 | 0.040 |
Why?
| | ROC Curve | 1 | 2022 | 500 | 0.040 |
Why?
| | Young Adult | 1 | 2017 | 12282 | 0.040 |
Why?
| | Epinephrine | 1 | 2021 | 140 | 0.040 |
Why?
| | Fatigue | 1 | 2022 | 316 | 0.040 |
Why?
| | Pneumonia, Viral | 1 | 2024 | 337 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1018 | 0.040 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 505 | 0.040 |
Why?
| | Middle Aged | 1 | 2020 | 30813 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2024 | 2509 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2022 | 4853 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 5378 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5034 | 0.020 |
Why?
| | Lung | 1 | 2024 | 3745 | 0.020 |
Why?
|
|
Navanandan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|